Keywords: کابرگولین; bromocriptine; cabergoline; inhibiteur de la prolactine; lisuride; quinagolide; bromocriptine; cabergoline; lisuride; prolactin inhibitor; quinagolide;
مقالات ISI کابرگولین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کابرگولین; Polycystic ovarian disease; Clomiphene citrate; Cabergoline; Ovulation; Euprolactinemia;
Keywords: کابرگولین; Ovarian hyperstimulation syndrome; Multipronged approach; Cabergoline; Vascular endothelial growth factor; Calcium gluconate;
Keywords: کابرگولین; Cushing's syndrome; Cushing's disease; Ketoconazole; Metyrapone; Mitotane; Etomidate; Cabergoline; Pasireotide;
Keywords: کابرگولین; Endometritis; Cystic endometrial hyperplasia; Escherichia coli; Endotoxemia; Aglepristone; Prostaglandin; Cabergoline; Bromocriptine;
Keywords: کابرگولین; Bromocriptine; cabergoline; dopamine agonist; hyperprolactinaemia; MRCP; prolactin; prolactinoma;
Keywords: کابرگولین; dog; cabergoline; estradiol benzoate; estrus induction;
Keywords: کابرگولین; Cabergoline; Carboxymethyl cellulose/maghemite nanocomposite; Modified carbon paste electrode; Electrochemical determination;
Keywords: کابرگولین; dairy cow; dry off; cabergoline; milk leakage; prolactin-release inhibitor;
Keywords: کابرگولین; Prolactinomas gigantes; Agonistas dopaminérgicos; CabergolinaGiant prolactinoma; Dopaminergic agonists; Cabergoline
Keywords: کابرگولین; Prolactin; Cabergoline; Dopamine; Mare; Anestrous
Keywords: کابرگولین; CD, Cushing's disease; CS, Cushing's syndrome; ACTH, adrenocorticotropic hormone; UFC, urinary free cortisol; MRI, magnetic resonance imagingCushing's; Pituitary adenoma; Adrenal; Mifepristone; Cabergoline; Pasireotide
Keywords: کابرگولین; Bromocriptine; Cabergoline; Dopamine agonist; Endoscopic endonasal transsphenoidal surgery; Pituitary tumor; Prolactinomas; Radiosurgery
Keywords: کابرگولین; Cabergoline; Female mice; Fertility control; Pregnancy;
Keywords: کابرگولین; Cabergoline; Rotigotine; Tacrine; Tremulous jaw movement; c-Fos; Parkinsonism
Keywords: کابرگولین; Pergolide; Cabergoline; Prolactin; Mares; Geldings;
Keywords: کابرگولین; Prolactinoma; Hyperprolactinaemia; Cabergoline; Bromocriptine; Pregnancy; GestationProlactinome; Hyperprolactinémie; Cabergoline; Bromocriptine; Grossesse; Gestation
In-vitro dissolution rate and molecular docking studies of cabergoline drug with β-cyclodextrin
Keywords: کابرگولین; Cabergoline; Phase solubility; β-cyclodextrin; Inclusion complex; Dissolution rate;
Diosmin versus cabergoline for prevention of ovarian hyperstimulation syndrome
Keywords: کابرگولین; Cabergoline; Diosmin; Infertility; ICSI; Ovarian hyperstimulation syndrome;
Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome
Keywords: کابرگولین; IVF outcome; Ovarian hyperstimulation syndrome; Cabergoline; VEGF; Résultats FIV; Syndrome de l'hyperstimulation ovarienne; Cabergoline; VEGF;
Seasonal Assessment of Duration of Prolactin Suppression Following Cabergoline Treatment in Mares: Unstimulated Versus Sulpiride and Thyrotropin-Releasing Hormone-Stimulated Responses
Keywords: کابرگولین; Season; Mare; Dopamine; Prolactin; Cabergoline;
Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial
Keywords: کابرگولین; Letrozol; Cabergoline; Myoma;
Combining several interventions to reduce the incidence of OHSS: A prospective cohort study
Keywords: کابرگولین; OHSS; ICSI; Cabergoline; Antagonist protocol; GnRH triggering;
Long-term and Short-term Dopaminergic (Cabergoline) and Antidopaminergic (Sulpiride) Effects on Insulin Response to Glucose, Glucose Response to Insulin, or Both in Horses
Keywords: کابرگولین; Cabergoline; Dopamine; Horse; Insulin sensitivity; Sulpiride;
Evaluation of the effects of cabergoline (Dostinex) on women with symptomatic myomatous uterus: a randomized trial
Keywords: کابرگولین; Myoma; Fibroid; Uterine bleeding; Uterus; Dopamine receptor agonist; Cabergoline;
Cabergoline in the Treatment of Male Orgasmic Disorder—A Retrospective Pilot Analysis
Keywords: کابرگولین; Anorgasmia; Male Orgasmic Disorder; Orgasm; Cabergoline
Prolactin is related to individual differences in parental behavior and reproductive success in a biparental passerine, the zebra finch (Taeniopygia guttata)
Keywords: کابرگولین; Prolactin; Parental care; Reproductive success; Individual variation; Zebra finch; Cabergoline
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study
Keywords: کابرگولین; Acromegaly; Lanreotide; Cabergoline; Pegvisomant; IGF-I; Somatostatin analogues; Acromegalia; Lanreotida; Cabergolina; Pegvisomant; IGF-I; Análogos de la somatostatina;
Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States
Keywords: کابرگولین; Bromocriptine; Cabergoline; Cost-effectiveness analysis; Endoscopic; Microprolactinoma; Microscopic; Pituitary tumors; Transsphenoidal surgery; CPT; Current Procedural Terminology; DI; Diabetes insipidus; DRG; Diagnosis-Related Group; ICER; Incremental co
Cabergoline Use for Pituitary Tumors and Valvular Disorders
Keywords: کابرگولین; Pituitary adenoma; Prolactinoma; Acromegaly; Cushing's disease; Cabergoline; Dopamine-agonists; Cardiac valve disease;
Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells
Keywords: کابرگولین; Dopamine; Lung cancer; VEGF; Cabergoline; Angiogenesis; Dopamine D2 receptor agonists; D2R; dopamine D2 receptor; LLC1; Lewis lung carcinoma 1; NSCLC; non-small cell lung cancer; VEGF; vascular endothelial growth factor A; EGFR; epidermal growth factor re
VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status
Keywords: کابرگولین; Ovarian Hyperstimulation; VEGF; Cabergoline
Long-term Treatment of Insulin-insensitive Mares with Cabergoline: Effects on Prolactin and Melanocyte Stimulating Hormone Responses to Sulpiride and on Indices of Insulin Sensitivity
Keywords: کابرگولین; Cabergoline; Prolactin; Mare; MSH; Insulin sensitivity
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials
Keywords: کابرگولین; Cabergoline; ovarian hyperstimulation syndrome; assisted reproductive techniques; ovulation induction; review;
Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch
Keywords: کابرگولین; IVF; OHSS; Cabergoline; Hydroxyethyl starch; Prevention;
Clinical outcome according to timing of cabergoline initiation for prevention of OHSS: a randomized controlled trial
Keywords: کابرگولین; cabergoline; oocyte maturation; ovarian hyperstimulation syndrome; metaphase-II rate; fertilization rate; pregnancy rate;
Thyrotropin-secreting pituitary tumor presenting with congestive heart failure and good response to dopaminergic agonist cabergoline
Keywords: کابرگولین; cabergoline; heart failure; hyperthyroidism; TSH-secreting pituitary tumors
Transsphenoidal microsurgical results of female patients with prolactinomas
Keywords: کابرگولین; Prolactinoma; Transsphenoidal surgery; Cabergoline; Macroadenoma; Pregnancy
Optimización del tratamiento médico de la acromegalia
Keywords: کابرگولین; Acromegalia; Análogos de somatostatina; Pegvisomant; Cabergolina; Tratamiento médicoAcromegaly; Somatostatin analogues; Pegvisomant; Cabergoline; Medical treatment
Pituitary apoplexy associated with cabergoline therapy
Keywords: کابرگولین; Bromocriptine; Cabergoline; Dopamine agonist; Pituitary apoplexy; Prolactinoma
Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study
Keywords: کابرگولین; OHSS; Dopamine agonist; RCT; Cabergoline;
Nuevas perspectivas en el tratamiento farmacológico de la enfermedad de Cushing
Keywords: کابرگولین; Enfermedad de Cushing; Tratamiento farmacológico; Pasireótida; CabergolinaCushing disease; Drug treatment; Pasireotide; cabergoline
Inhibition de la lactation dans le post-partum : bromocriptine versus cabergoline
Keywords: کابرگولین; Agonistes dopaminergiques; Bromocriptine; Cabergoline; Inhibition lactation; Post-partum; Bromocriptine; Cabergoline; Agonists; D2 dopamine receptor; Puerperium;
Medical Versus Surgical Management of Prolactinomas
Keywords: کابرگولین; Prolactinomas; Pituitary adenoma; Dopamine agonist; Bromocriptine; Cabergoline; Transsphenoidal surgery;
Cabergoline vs intravenous albumin or combination of both for prevention of the early onset ovarian hyperstimulation syndrome
Keywords: کابرگولین; Cabergoline; I.V Albumin; OHSS; Prevention; ART
Hyperprolactinemia and Infertility
Keywords: کابرگولین; Prolactin; Infertility; Bromocriptine; Cabergoline; Pituitary tumor;
Prolactinoma in pregnancy
Keywords: کابرگولین; prolactin; prolactinoma; pregnancy; adenoma; tumor; cabergoline; bromocriptine; malformation; microadenoma; macroadenoma; hyperprolactinemia; infertility
NeuropharmacologyResearch PaperChanges of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias
Keywords: کابرگولین; glutamate; motor complications; Parkinson; cabergoline; CI-1041; dopamine; DA; dopamine; DL; dorso-lateral; DM; dorso-medial; l-DOPA; levodopa; LTD; long-term depression; LTP; long-term potentiation; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;
High dose cabergoline in management of ovarian hyperstimulation syndrome
Keywords: کابرگولین; Ovarian hyperstimulation syndrome; vascular endothelial growth factor; cabergoline; dopamine; prevention; treatment;
Adjuncts for ovarian stimulation: when do we adopt “orphan indications” for approved drugs?
Keywords: کابرگولین; Ovarian stimulation; metformin; dexamethazone; hCG; aspirin; cabergoline; androgens